Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis C.
Morio K, Imamura M, Kawakami Y, Morio R, Hatooka M, Kan H, Fujino H, Fukuhara T, Kobayashi T, Masaki K, Ono A, Nakahara T, Urabe A, Yokoyama S, Nagaoki Y, Kawaoka T, Hiraga N, Tsuge M, Hiramatsu A, Hayes CN, Aikata H, Ochi H, Chayama K; Hiroshima Liver Study Group.
Morio K, et al. Among authors: chayama k.
Hepatol Res. 2016 Nov;46(12):1256-1263. doi: 10.1111/hepr.12681. Epub 2016 Apr 5.
Hepatol Res. 2016.
PMID: 26916827